Immunotherapy

Article	Citations
Identifying risk factors and biomarkers for severe CIP in lung cancer patients– a retrospective case series study	76
Atezolizumab and Bevacizumab prior to liver transplantation in hepatic angiosarcoma mimicking hepatocellular carcinoma	66
Uric acid level in metastatic renal cell carcinoma treated with nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) study	57
Real-world Study of Hepatic Artery Infusion Chemotherapy Combined With Anti-PD-1 Immunotherapy and Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma	45
Cost–Effectiveness Analysis of Serplulimab as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma	36
An Update on the Adalimumab Biosimilar Landscape Following Approval of the First High-Concentration Biosimilar	31
Imaging of brain metastases treated with immune checkpoint inhibitors	31
Real-World Outcomes with Immuno-Oncology Therapies in Advanced Melanoma: Final Results of the OPTIMIzE Registry Study	31
Alemtuzumab-Induced Red Cell Aplasia And Other Immune Cytopenias: Not So €˜Pure’	28
Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor Pd-L1 Expression in Asia	27
Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-158	25
Postvaccination immune-mediated hepatitis: what do we really know?	25
Therapeutic lymph node dissection with neoadjuvant immunotherapy for macroscopic melanoma – too much skin in the game?	21
Safety and Effectiveness of the 300 IR Sublingual House Dust Mite Allergen Immunotherapy Tablet: 2-Year Interim Analysis of a Specified Drug-Use Survey	20
Targeting PD-1/PD-L1 in Biliary Tract Cancer: Role and Available Data	17
Pd-1, Pd-L1, Ido, Cd70 and Microsatellite Instability as Potential Targets to Prevent Immune Evasion in Sarcomas	16
Subcutaneous Immunoglobulin Use in Immunoglobulin-Naive Patients with Primary Immunodeficiency: A Systematic Review	15
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors	15
Treatment and Overall Survival Among Anti-PD-1-Exposed Advanced Melanoma Patients with Evidence of Disease Progression	15
Immunotherapy for Gastric Cancer: A 2021 Update	15
Immune Checkpoint Inhibitors Use and Effects on Prognosis of COVID-19 Infection: A Systematic Review and Meta-Analysis	14
Safety and Efficacy of Mutant Neoantigen-Specific T-Cell Treatment Combined Anti-Pd-1 Therapy in Stage Iv Solid Tumors	13
Low-Dose Metronomic Gemcitabine Pretreatments Overcome the Resistance of Breast Cancer to Immune Checkpoint Therapy	13
Adherence, persistence and treatment switching in psoriasis	13
Durvalumab after Chemoradiotherapy in Patients with Stage III Non-Small-Cell Lung Cancer: Real-World Outcomes Versus Clinical Trial Results	12

What is the future of immune checkpoints inhibitors for metastatic triple negative breast cancers?	12
Anlotinib Succeeded in Rescue Therapy For Hyperprogression Induced by Immune Checkpoint Inhibitors: A Case Report	12
Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review	12
Nivolumab induced discolouration of the tongue: a case report	12
Assessing Pd-L1 Status in Mrcc Treated with First-Line Immune-Based Combinations: A Meta-Analysis	12
Prognostic Value of Soluble Programmed Cell Death Ligand-1 in Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis	12
4-1BB Antibody Enhances Cytotoxic Activity of Natural Killer Cells Against Prostate Cancer Cells Via NKG2D Agonist Combined with IL-27	12
Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors	12
Cancer Immunotherapy Via Stem Cell-Derived NK Cells	12
Uveitis Associated with Cancer Immunotherapy: Long-Term Outcomes	12
Efficacy of mIte Allergen Immunotherapy in Allergic Rhinitis and the Immune Synergistic Effect on Cross-Allergens	11
Cost–Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Treatment in PD-L1-Positive Metastatic Triple-Negative Breast Cancer	11
Immune Checkpoint Inhibitors in Cholangiocarcinoma	10
Current Immunosuppression Strategies in Pediatric Heart Transplant	10
Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management	10
Dendritic Cell-Based Immunotherapy: A Potential Player in Oral Cancer Therapeutics	10
Effectiveness of allergen immunotherapy with house dust mite extract for pediatric bronchial asthma	10
Emerging Advances in Nanomedicine for Breast Cancer Immunotherapy: Opportunities and Challenges	10
Applications and Current Challenges of Chimeric Antigen Receptor T Cells in Treating High-Grade Gliomas in Adult and Pediatric Populations	10
Immune-Checkpoint Inhibitors in Renal Transplanted Patients Affected by Melanoma: A Systematic Review	10
Lessons From the Diagnosis and Treatment of Severe Immune Checkpoint Inhibitor-Associated Pneumonia: A Case Report	10
Deucravacitinib in Moderate-To-Severe Psoriasis	10
SAFFRON-103: A Phase Ib Study of Sitravatinib Plus Tislelizumab in Anti-PD-(L)1 Refractory/Resistant Advanced Melanoma	10
Sintilimab-induced severe erosive hemorrhagic gastritis and pyloric obstruction: a case report and literature review	10
Durvalumab in Advanced Cholangiocarcinoma: Is Someone Knocking Down the Door?	10
Infection Rates and Tolerability of Three Different Immunoglobulin Administration Modalities in Patients with Primary Immunodeficiency Diseases	10
Molecular Interactions of Antibodies with PD-1/PD-L1 Proteins	10
Liquid biopsy for guiding breast cancer immunotherapy	10
Integrase inhibitors: current protagonists in antiretroviral therapy	9
Immune-Related Gigantomastia: A Case Study	9
A Summertime Pause in Immunoglobulin Replacement Therapy: A Prospective Real-World Analysis	9
Indirect Comparison of Pembrolizumab Monotherapy Versus Nivolumab + Ipilimumab in First-Line Metastatic Lung Cancer	9
Human Growth Hormone Supplement Promotes Human Lymphohematopoietic Cell Reconstitution in Immunodeficient Mice	9
Antithymocyte Globulin for Aplastic Anemia Secondary to Pembrolizumab: A Case Report and Review of Literature	9
Effectiveness of COVID-19 Vaccines Against Omicron Variant	9
Immune Checkpoint Inhibitor-Induced Autoimmune Encephalitis in Metastatic Squamous Cell Lung Cancer	9
Treatment of Plaque Psoriasis with Deucravacitinib (POETYK PSO-1 Study): A Plain Language Summary	9
Poor Response to Sintilimab Plus Chemotherapy in a Pulmonary Epithelioid Hemangioendothelioma Patient: A Case Report	9
Breaking the mold: nontraditional approaches to allergen immunotherapy for environmental allergens	9
Steroid-Dependent Polyarthritis Induced by Immune Checkpoint Inhibitor Therapy Successfully Treated with Bimekizumab	8
Autophagy in combination therapy of temozolomide and IFN-γ in C6-induced glioblastoma: role of non-coding RNAs	8
TOPAZ-1: A New Standard of Care for Advanced Biliary Tract Cancers?	8
A Meta-Analysis of Application of Pd-1/Pd-L1 Inhibitor-Based Immunotherapy in Unresectable Locally Advanced Triple-Negative Breast Cancer	8
Infectious Adverse Events in Patients with Atopic Dermatitis Treated with Baricitinib	8
Immune Checkpoint Inhibitors in Lung Tumors with Rare Histologies and Other Thoracic Malignancies	8
Peripheral blood cytokines and outcomes with immune checkpoint blockade: a systematic review and meta-analysis	8
Abrocitinib for the Treatment of Atopic Dermatitis	8
Therapeutic Intervention of Glioma with the Novel Antineoplastic Agent T11TS: The Story so Far	8
Mepolizumab in Chronic Rhinosinusitis with Nasal Polyposis	8
Ipilimumab and Nivolumab: The ‘New Kid on the Block’ in Advanced Angiosarcoma	8

Impact of Helicobacter Pylori Infection on The Efficacy of Immune Checkpoint Inhibitors for Cancer Treatment: A Meta-Analysis	8
Fulminant immune-related colitis after dual checkpoint inhibitor therapy: case report	8
Late-Onset Toxicities of Monoclonal Antibodies in Cancer Patients	8
Lebrikizumab decreases type 2 inflammatory biomarker levels in patients with asthma: data from randomized phase 3 trials (LAVOLTA I and II)	7
Combination of Methotrexate with Oral Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: A Systematic Review	7
Established and Emerging Biomarkers of Immunotherapy in Renal Cell Carcinoma	7
Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy	7
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab	7
Optimizing TIL therapy for uveal melanoma: lessons learned and unlearned from cutaneous melanoma	7
An Abscopal Effect in a Gastric Cancer Patient Treated with Combined Chemoimmunotherapy and Palliative Radiotherapy	7
Cost-effectiveness of Upadacitinib vs. Tofacitinib for moderate-to-severe rheumatoid arthritis in China	7
Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease	7
Simultaneous Inhibition of PD-1 and LAG-3: the Future of Immunotherapy?	7
Evaluating the Effectiveness of the Charlson Comorbidity Index in Predicting Immune Checkpoint Inhibitor-Related Adverse Events	7
Pembrolizumab in an HIV-infected patient with glioblastoma	7
Ocular Toxicities in Chimeric Antigen Receptor T-Cell Therapy: A Real-World Study Leveraging FAERS Database	7
Immunotherapies for prevention and treatment of type 1 diabetes	7
Long-Term Response to Camrelizumab in a Pretreated Metastatic Mixed Testicular Germ-Cell Tumor Patient with Co-Mutations in DNA Damage-Repair Genes	7
Indications and Effects of Biological Agents in the Treatment of Noninfectious Uveitis	7
Venous Thromboembolism Events in Patients with Advanced Cancer on Immune Checkpoint Inhibitors	7
An Unusual Case of Immune-Related Gastritis in One Patient Receiving Toripalimab Therapy	6
Infrequent Liver Injury from Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma	6
Allogeneic CAR-T cells for cancer immunotherapy	6
Evaluating Axatilimab as a treatment option for chronic graft-versus-host disease	6
Updated Insights on Cardiac Risks of CD19-Directed Chimeric Antigen Receptor T-cell Therapy: A Pharmacovigilance Study	6
Treatment of Plaque Psoriasis with Deucravacitinib (Poetyk Pso-2 Study): A Plain Language Summary	6
The Development of Litifilimab (BIIB 059) for Cutaneous and Systemic Lupus Erythematosus	6
Anaphylaxis to Tocilizumab in Patients with Rheumatic Disease	6
A New Perspective on The Potential Application of Ripk1 in the Treatment of Sepsis	6
Oncolytic Viruses in Lung Cancer Treatment: A Review Article	6
Moving Beyond Single-Agent Checkpoint Inhibition in Biliary Tract Cancers: What is the Next Frontier?	6
Immunotherapeutic effects of TCL-E5 and TCL-E5-pulsed DCs: two novel HPV therapeutic vaccine candidates	6
Mirikizumab for the Treatment of Moderate to Severe Ulcerative Colitis	6
Pathological Findings Directing Immunotherapy in Renal Cell Carcinomas	6
Could senescent cells be the prescription for therapeutic cancer vaccines?	6
Cutaneous Metastases at the Sites of Pembrolizumab-Induced Bullous Pemphigoid Lesions in a Patient with Melanoma	6
Treatment of EAE Mice with Treg, G-MDSC and IL-2: a New Insight into Cell Therapy for Multiple Sclerosis	6
Peptide–MHC Complexes: Dressing up to Manipulate T Cells Against Autoimmunity and Cancer	6
Targeting the Tumor Microenvironment of Ewing Sarcoma	6
The Effect of Low-Dose Chemotherapy on the Tumor Microenvironment and its Antitumor Activity Combined with Anti-PD-1 Antibody	6
Mitigation strategies for gastrointestinal (GI) immune-related adverse events for patients with solid tumors receiving immunotherapy	6
Plain Language Summary of principles for improving the care of people with eosinophil-associated diseases	6
Application of immune checkpoint inhibitors in immunotherapy for gastric cancer	6
Fractional Exhaled Nitric Oxide in Checkpoint Inhibitor Pneumonitis: A Case Report and Literature Review	6
Intratumoral Delivery of Immune Therapy and Gene Therapy: The Next Era for Cancer Therapy	6
A novel dose-adjustment protocol for interrupted subcutaneous immunotherapy in children with allergic rhinitis	6
Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapy	6
Neoadjuvant Immunochemotherapy in the Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: A Systematic Review	6
Safety and Effectiveness of a 300 IR House Dust Mite Sublingual Tablet: Descriptive 4-Year Final Analysis of a Post-Marketing Surveillance in Japan	6
Summary of Certolizumab Pegol in Psoriasis Including Structural Features, Pharmacokinetics and Treatment	5
Bimekizumab for The Treatment of Psoriasis	5
Successful Use of Secukinumab in Two Melanoma Patients with Immune Checkpoint Inhibitor-Induced Inflammatory Arthropathy	5
Peripheral Blood Eosinophil Count is Associated with Response to Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer	5
ICAM2 is Related to Good Prognosis in Dendritic Cell Immunotherapy for Cancer	5
Pd-1/L1 Inhibitors May Increase the Risk of Pericardial Disease in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis and Systematic Review	5
Real-World Study: Drug Reduction in Children With Allergic Rhinitis and Asthma Receiving Immunotherapy	5
A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents	5
The Use of Dostarlimab, a Safe and Efficient Monotherapy in Msi-H Rectal Cancer Patients, an Alternative to Surgery	5
Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event	5
Mirna Profiles Change During Grass Pollen Immunotherapy Irrespective of Clinical Outcome	5
Multicenter Real-World Experience with Epinephrine 0.5 mg Dosing for Anaphylaxis with Allergen Immunotherapy	5
Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors	5
Pancreas-specific immune-related adverse events in patients with lung cancer: a case series study	5
Tsunami of Immunotherapies in the Management of Esophageal Cancer	5
Effect of Helicobacter Pylori infection on immunotherapy for gastrointestinal cancer: a narrative review	5
A CD123-Specific Chimeric Antigen Receptor Augments Anti-Acute Myeloid Leukemia Activity of Vγ9Vδ2 T Cells	5
Amalgamation of Nanotechnology with Chicken IgY to Enrich Therapeutic and Diagnostic Applications: A Systematic Review	5
Efficacy of Long-Term Repeated Rituximab Treatment in Refractory Phospholipase A2 Receptor-Antibody-Related Membranous Nephropathy	5
Combination of immunotherapy and fruquintinib in metastatic colorectal cancer: the key to overcome resistance?	5
Immunotherapy for Head and Neck Squamous Cell Carcinoma: Current Status and Perspectives	5
Cemiplimab-Induced Cytokine-Release Syndrome: Second Case Reported and Review of The Literature	5
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease	5
Pembrolizumab: A New Standard of Care in Metastatic Colorectal Cancer	5
Radiation and Resolve: Unlocking the Synergistic Potential of Radioimmunotherapy in Advanced Lung Cancer Management	5
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations	5
Pegcetacoplan Treatment for Geographic Atrophy Due to Age-Related Macular Degeneration: A Plain Language Summary of the FILLY Study	5
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement	5
Pharmacokinetics and Safety of CT-P17 (40 mg/0.4 ml) Versus Reference Adalimumab: Randomized Study in Healthy Japanese Adults	5
Nutritional conditions and PFS and OS in cancer immunotherapy: the MOUSEION-010 meta-analysis	5
Durable Response after Immunotherapy Discontinuation for Delayed and Severe Immune-related Adverse Event: A Case Report	4

Immunoglobulin therapies for primary immunodeficiency diseases (part 1): understanding the pharmacokinetics	4
Safety and Effectiveness of Intravenous Ct-P13 in Inflammatory Arthritis: Post-Marketing Surveillance Study in Thailand	4
Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events	4
Tezepelumab for the Treatment of Severe Asthma: A Plain Language Summary of the PATHWAY and NAVIGATOR Studies	4
Drug evaluation: mepolizumab in chronic obstructive pulmonary disease	4
Late-onset recurrent immune checkpoint inhibitor-related pneumonitis after cessation of pembrolizumab: a case report	4
Immunotherapy in Atopic Dermatitis	4
Systemic Immune–Inflammation Index Predicts Prognosis of Cancer Immunotherapy: Systemic Review and Meta-Analysis	4
A Review of Phase Iii Clinical Trials of Us Fda-Approved Biologic Therapies for Chronic Rhinosinusitis with Nasal Polyposis	4
Evidence for optimal treatment of immune-related adverse events needed – should we use extracorporeal photopheresis?	4
Safety of Subcutaneous and Sublingual Immunotherapy with Allergoids in Children: A Real-Life Pharmacovigilance Study	4
Anti-PD-1 and Regorafenib Induce Severe Multisystem Adverse Events in Microsatellite Stability Metastatic Colorectal Cancer: A Case Report	4
Metastatic Gastric Cancer: Synergizing and Sequencing Targeted Therapy with First-Line Immunotherapy	4
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy	4
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation	4
Severe Pseudomembranous Keratoconjunctivitis with Deterioration of Eyesight Induced by Immune Checkpoint Inhibitors	4
Immune Checkpoint Inhibitors and Combinations with Other Agents in Cholangiocarcinoma	4
Overcoming Immune-Resistance in Laryngeal Cancer: A Case Report of the Abscopal Effect and Nivolumab Beyond Progression	4
Thyroid Function Impairment after Chemo-Immunotherapy for Advanced Nsclc: A Single Institutional Retrospective Report	4
Effect of Neoadjuvant Therapy on Tumor Tissue PD-L1 and VISTA Expression Levels in Non-Small-Cell Lung Cancer	4
Satisfaction, Qol and adherence of patients allergic to dust mites and/or pollens undergoing sublingual immunotherapy	4
Immune checkpoint inhibitor-related colitis in a patient with non-small cell lung cancer co-infected with HBV and EBV: a case report	4
Welcome to The 14th Volume of Immunotherapy	4
Immunoregulatory Effects of Dental Mesenchymal Stem Cells on T and B Lymphocyte Responses in Primary Sjögren's Syndrome	4
Enhanced Binding at Fever Temperatures of HER2 in Complex with Trastuzumab and Pertuzumab	4
Immune Checkpoint Inhibitors for Advanced or Metastatic Basal Cell Carcinoma: How much Evidence do we Need?	4
Pembrolizumab-Induced Follicular Eruption and Response to Isotretinoin	4
Cost–Effectiveness Analysis of Nivolumab Plus Cabozantinib Versus Sunitinib as First-Line Therapy in Advanced Renal Cell Carcinoma	4
The combination of immune checkpoint inhibitors and chemotherapy in advanced non-small-cell lung cancer: the rational choice	4
Imaging-calculated splenic volume is associated with response in melanoma patients treated with immunotherapy	4
Clinical Outcomes of Immune Checkpoint Inhibitor Diabetes Mellitus at a Comprehensive Cancer Center	4
Pembrolizumab-induced myocarditis, myositis, and myasthenia gravis overlap syndrome (IM3OS) treated with Efgartigimod: case report	4
Oncolytic immunovirotherapy: finding the tumor antigen needle in the antiviral haystack	4
Health-related Quality of Life in Patients with Melanoma Brain Metastases Treated with Immunotherapy	4
Complete Response and Survival Outcomes in Patients with Advanced Cancer on Immune Checkpoint Inhibitors	3
FHL1 As a Novel Prognostic Biomarker and Correlation with Immune Infiltration Levels in Lung Adenocarcinoma	3
Combined Application of Bevacizumab and Pd-1 Blockade Displays Durable Treatment Effects by Increasing the Infiltration And Cytotoxic Function of Cd8 + T Cells in Lu	3
Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study	3
Surrogate end Points for Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors	3
Immunology of Osteoporosis: Relevance of Inflammatory Targets for the Development of Novel Interventions	3
Reversing Chemokine/Chemokine Receptor Mismatch to Enhance the Antitumor Efficacy of CAR-T Cells	3
Efficacy of Therapies Targeting TGF-β in Solid Tumors: a Systematic Review and Meta-Analysis of Clinical Trials	3
Benralizumab for the treatment of chronic spontaneous urticaria: a plain language summary of the ARROYO study	3
Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors	3
Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary	3
Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases	3
Avoided recurrences and costs with adjuvant atezolizumab for patients with early non-small cell lung cancer in Europe	3
Outcomes for Pembrolizumab Stratified by Pemetrexed Maintenance Post Pembrolizumab–Platinum–Pemetrexed Induction in Metastatic Non-Small-Cell Lung Cancer	3
Immune Checkpoint Inhibitor-Related Chronic Pneumonitis: A Case Report and Literature Review	3
The role of nemolizumab in the treatment of atopic dermatitis for the adult population	3
Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutation	3
Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient	3
A Common Approach for Fighting Tuberculosis and Leprosy: Controlling Endoplasmic Reticulum Stress in Myeloid-derived Suppressor Cells	3
Interpatient Variability in Mesothelin Expression Necessitates its Evaluation Before Gastric Cancer Immunotherapy	3
Autologous Enzyme-Linked Immunosorbent Facilitated Antigen Binding Detects Ige-Blocking Activity Based on Direct Competition between Allergen-specific IgE and Non-IgE	3
Cost–effectiveness of Adjuvant Atezolizumab for Patients with Stage II–IIIA PD-L1+ Non-Small-Cell Lung Cancer	3
IgE-mediated anaphylaxis induced by pembrolizumab	3
Lichenoid Drug Eruption on the Lower Lip Caused by Anti-PD-1 Monoclonal Antibody: A Case Report and Literature Review	3
Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors	3
Galectin-9 and PD-L1 Antibody Blockade Combination Therapy Inhibits Tumour Progression in Pancreatic Cancer	3
Comparing how Well Abrocitinib and Dupilumab Treat Atopic Dermatitis Signs and Symptoms: A Plain Language Summary	3
Prognostic value of peripheral blood neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, pan-immune-inflammation value and systemic immune-inflammation index for the efficacy of immunotherapy in p	3
Efficacy of Pd-1/Pd-L1 Inhibitors in Advanced Gastroesophageal Cancer Based on Characteristics: A Meta-Analysis	3
Sintilimab Plus Sorafenib: A novel Regimen for Hepatocellular Carcinoma	3
Targeting CD47 Enhanced the Antitumor Immunity of PD-L1 Blockade in B-Cell Lymphoma	3
CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand?	3
Etrasimod for the Treatment of Ulcerative Colitis	3
Treatment and Prognostic Implications of Strong PD-L1 Expression in Primary Hepatic Sarcomatoid Carcinoma	3
Alpha/beta-defensins influence on the humoral immunity and complications in cancer of the oral cavity and oropharynx	3
Plain Language Summary of the VOLTAIRE-RA in Patients with Moderate-To-Severe Rheumatoid Arthritis	3
Combination of Bevacizumab and Dual Immunotherapy for Extensive-Disease Small-Cell Lung Cancer: A Case Report	3
The Evolution of Biliary Tract Cancer: Introducing a Special Focus Issue from Immunotherapy	3
The Emerging Role of Immunotherapy in Biliary Tract Cancer: A Review of New Evidence and Predictive Biomarkers	3
Targeted Allergen-Specific Immunotherapy within the Skin Improves Allergen Delivery to Induce Desensitization to Peanut	3
Immunotherapy for Head and Neck Cancer: Where do We Go from Here?	3
The role of immune subtyping in glioma mRNA vaccine development	3
The role of dupilumab in the treatment of eosinophilic esophagitis	3
Helminth-derived biomolecules as potential therapeutics against ulcerative colitis	3
Penpulimab and Anlotinib in an Elderly Patient with Recurrent Cervical Cancer: A Case Report and Literature Review	3
Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis in a Patient with Chronic Lymphocytic Leukemia	3
Efficacy of PD-1/PD-L1 Plus CTLA-4 Inhibitors in Solid Tumors Based on Clinical Characteristics: a Meta-Analysis	2
Toripalimab and Fruquintinib Therapy for Colorectal Cancer after Failed Multiline Chemotherapies: A Case Report	2
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data	2
Impact of immune-related adverse events on survival among patients with head-and-neck squamous cell carcinoma	2
Absence of pre-transplant T cell response against LAA is associated with Flt3-ITD mutation and increased relapse-risk in AML patients with HSCT	2
Cost–effectiveness analysis of immune checkpoint inhibitors as first-line therapy in advanced biliary tract cancer	2
Use of Upadacitinib in the Treatment of Psoriatic Arthritis	2
Evaluating remibrutinib in the treatment of chronic spontaneous urticaria	2
How could histotripsy change cancer immunotherapy?	2
Evaluation of Appendectomy as A Potential Risk Factor for Immune Checkpoint Inhibitor-Associated Enterocolitis	2
Immunotherapy with γδ T-cells: the future is there	2
Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trials	2
Hematological Prognosticators in Metastatic Renal Cell Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis	2
The role of exosomal PD-L1 in NSCLC immunotherapy	2
Anti-PD-1 Treatment-Induced Immediate Central Diabetes Insipidus: A Case Report	2